WASHINGTON—Imagine an endocrinology division staffed with endowed researchers, endocrinologists, and other specialists, that serves as an engine of innovation, making it easy for pediatricians to refer patients to entire endocrinology teams for cutting-edge care.
Over the next few years, Andrew Dauber, M.D., MMSc, the new chief of endocrinology at Children’s National will work with the nationally-ranked endocrinology and diabetes division at Children’s National to build this type of robust endocrinology research program, housing specialty clinics for Turner’s syndrome, thyroid care and growth disorders, amongst others.
“Researchers, clinicians and medical trainees are pressed for time,” notes Dr. Dauber. “Merging these three arenas into a joint infrastructure powers institutional collaboration and fuels transformative care.”
To put his real-life hypothesis, providing an engine for innovation, into practice, Dr. Dauber led the interdisciplinary growth center at Cincinnati Children’s Hospital Medical Center and organized a Genomics First for Undiagnosed Diseases Program to study genetic clues for undiagnosed diseases. At Boston Children’s Hospital, he was the assistant medical director for the clinical research unit and held academic appointments with Harvard Medical School.
Dr. Dauber finds it’s critically important to merge clinical practice with research and education. He received his medical degree and a master’s of Medical Sciences in Clinical Investigation from Harvard Medical School. He has published more than 65 studies examining genetic clues to endocrine disorders, with a focus on short stature and growth disorders.
Dr. Dauber conducted the majority of his research—ranging from studying genetic clues for rare growth disorders and causes of precocious puberty to genes that regulate the bioavailability of IGF1, insulin-like growth factor—while counseling patients, advising students and fellows, managing grants, reviewing studies and speaking at international pediatric endocrinology conferences.
He’s harnessing this data by combining genomic insights with electronic health records and patient registries. While some of this information can be used immediately to identify a high-risk patient, other conditions may take years to understand. Dr. Dauber views this as an investment in the future of pediatric endocrinology.
“I’m excited to join Children’s National and to work in Washington, where we can power our city and the nation with premier partnerships and collaboration,” adds Dr. Dauber. “In addition to using genetic clues to investigate growth disorders, we’re just as enthusiastic about investing in and expanding access to youth-focused diabetes education and care.”
The Division of Diabetes and Endocrinology works with the National Institutes of Health, conducts independent research, and received support from the Washington Nationals Dream Foundation for its diabetes program, the largest pediatric diabetes program in the region, which provides community education and counsels 1,800 pediatric patients each year.
Media contact: Jessica Frost | 301-244-6721 | 202-476-4500